1. Glycine B as drug target for the treatment of neurological disorders
2. Synthetic antigen based malaria vaccine
3. Combination of therapy for the treatment of schizophrenia and bipolar disorder
4. Taxol for the treatment of atherosclerosis
5. MicroRNAs as drug targets for the treatment of chronic, non-healing wounds and acute wounds
6. MicroRNAs for the treatment of age-related macular degeneration or proliferative vitreal retinopathy
7. PYY peptide analogues for the treatment of diabetes and obesity
8. Neuregulin for the treatment of myocardial ischemia reperfusion injury
9. A1 adenosine receptor as drug target for the treatment of renal impairment
10. IL-7 receptor (CD127) as a drug target for the treatment of multiple sclerosis
11. Bifunctional inhibitors of DNA replication and repair proteins for the treatment of cancer
12. Inhibitors of SI00 protein binding interactions for the treatment of cancer
13. Low-affinity nerve growth factor receptor (NGFR) as a marker for differentiation in muscle stem cells
14. Differentiation of MSCs from pluripotent cells using activin and TGF-beta inhibitors
15. Depletion of pluripotent stem cells from a mixed cell population
16. Placental stem cells for the treatment of bone cancer
17. Isolation of multipotent cardiovascular progenitors from stem cells using cell surface markers
18. HSS1 and HSM1 proteins for the treatment of brain cancers
19. Prominin-1 derived peptides as angiogenesis agents
20. Peptide based combination therapy for obesity and diabetes
21. PDE1 inhibitor to treat pathological cardiac remodeling and heart failure
22. GPR119 G protein-coupled receptor modulators for the treatment of diabetes
23. Low molecular weight CDK inhibitor for the treatment of glioblastoma
24. Pyridine and pyrimidine based compounds as inhibitors of Wnt signaling for the treatment of cancer
25. Anti-cancer vaccine DNL complexes using dock-and-lock technology
26. DII4 as drug target of autoimmune diseases
27. C-peptide for treating erectile dysfunction associated with diabetes
28. Src family kinase /Nef protein interaction as a drug target for HIV-I
29. Cyclic tetrapeptide kappa opioid receptor (KOR) antagonists for the treatment of drug addiction
30. Combination therapy for cancer using oligonucleotide inhibitors of IGFBPs and clusterin
31. Wax synthase activity of a MTTGS as a drug target for tuberculosis
32. Nkx3.2 protein as a therapeutic drug target of osteoarthritis
33. Oligonucletode based inhibitors of PWWP domain protein for the treatment of neuroblastoma
Details: http://www.sciclips.com/sciclips/drug-discovery-news.do
No comments:
Post a Comment